Document:

Loan Agreement

 Exhibit 10.15 
 LOAN AGREEMENT 
 Dated as of May 9, 2008 
 by and between 
 MONTAGE CAPITAL , LLC 
 as Montage 
 AGILITY CAPITAL, LLC

 as Agility 
 and 

ALPHA INNOTECH CORP., a Delaware corporation and 
 ALPHA INNOTECH CORPORATION, a California corporation 
 collectively, as Borrower 
 TOTAL CREDIT AMOUNT: Up to $1,500,000 
  

			
	Maturity Date:	  	October 31, 2009
	Formula:	  	None
	Facility Origination Fee:	  	$30,000
	Interest:	  	13% Fixed
	Warrants:	  	See Warrants

 The information set forth above is subject to the terms and conditions set forth in the balance of this Agreement.
The parties agree as follows: 
  

 1. 

 1. Advance and Payments. 
 Advance. Borrower may request one advance (the “Advance”), up to $1,500,000. The obligation of Montage and/or Agility
(each a “Lender” and collectively, the “Lenders”) to make the Advance under this Agreement is subject to (i) each Lender’s reasonable determination, in its sole discretion, that there has not occurred a circumstance or
circumstances that have a Material Adverse Effect, as defined in Section 5(g), and (ii) the execution, delivery and filing of such instruments and agreements, as Lenders reasonably deem appropriate. Each Lender shall be responsible only
for the percentage of the Advance set forth below its signature (“Pro Rata Share”). Borrower shall make all payments due under this Agreement to Agility. Agility shall have the responsibility to pay Montage its Pro Rata Share of all such
payments. 
 (a) Payments. Borrower shall pay interest on the outstanding principal balance of the Advance at a fixed
rate per annum equal to 13%. Interest shall be calculated on the basis of a 360-day year for the actual number of days elapsed, and shall be payable in arrears on the first day of each month. Any partial month shall be prorated on the basis of a
30-day month based on the actual number of days outstanding. Beginning June 1, 2008, and continuing on the first day of each month thereafter, Borrower shall repay Lenders $45,000 of the outstanding principal balance of the Advance plus accrued
interest. Borrower may prepay all or any part of any Advance without penalty or premium[, but may not reborrow any amount repaid]. Prepayments shall be applied first to fees, then to interest, then to principal installments in reverse order of
maturity. 
 (b) Fees. Borrower shall pay Lenders an origination fee of $30,000 on the date of this Agreement.

 (c) Warrants. Alpha Innotech Corp. is concurrently issuing to each Lender a Warrant to Purchase Stock (each
“Warrant”). 
 (d) Maturity Date. All amounts outstanding hereunder are due and payable on October 31,
2009 (the “Maturity Date”). 
 (e) Late Payment; Facility Fee; Default Payment. Prior to the Maturity Date,
if any payment of interest or any other amount owing to Agility is not made within ten (10) days after the due date, Borrower shall pay Agility a late payment fee equal to 5% of such amount. If any amount is outstanding under this Agreement on
December 31, 2008, Borrower shall pay Lenders a fee of $7,500. If any amount is outstanding under this Agreement on May 7, 2009, Borrower shall pay Lenders a fee of $7,500. After the occurrence and during the continuance of an Event of
Default, the Obligations shall bear interest at a rate equal to 18% per annum. In addition, on the day after the occurrence of an Event of Default, if any amount is outstanding under this Agreement, Borrower shall pay Lender a fee of $2,500; on
the 15th day thereafter, and on every 15th day after that, for so long as any amount is still outstanding, Borrower shall pay Lender an additional $2,500. In addition, each Lender shall have a right to purchase additional shares under the Warrant,
as specified in the Warrant. The terms of this paragraph shall not be construed as Lenders’ consent to Borrower’s failure to pay any amounts in strict accordance with this Agreement, and Lenders’ charging any such fees and/or
acceptance of any such payments shall not restrict any exercise of any remedies arising out of any such failure. 
 2. Security
Interest. As security for all present and future indebtedness, guarantees, liabilities, and other obligations of Borrower to Lenders under this Agreement, including all fees specified in Section 1 (collectively, the
“Obligations”), Borrower grants each Lender a security interest in all of Borrower’s personal property, whether now owned or hereafter acquired, including without limitation all of the following: all accounts, cash, patents,
copyrights, trademarks, goodwill, general intangibles, chattel paper, documents, letters of credit, instruments, deposit accounts, investment property, inventory, fixtures and equipment, as such terms are defined in Division 9 of the Uniform
Commercial Code in effect on the date hereof, the property described on Exhibit A attached hereto, and all products, proceeds and insurance proceeds of the foregoing (collectively, the “Collateral”). Borrower authorizes each Lender
to execute such documents and take such actions as such Lender reasonably deems appropriate from time to time to perfect or continue the security interest granted hereunder. Within 10 business days after the closing, Borrower will deliver to Lenders
one or more account control agreements in form reasonably acceptable to Lenders covering all of Borrower’s bank accounts. 
  

 2. 

 3. Representations and Warranties; Affirmative Covenants. Borrower represents to Lenders as
follows (which shall be deemed continuing throughout the term of this Agreement, except to the extent that any such representation relates to a specific prior date), and shall do as follows: 
 (a) Authorization. Borrower is and will continue to be, duly organized, validly existing and in good standing under the laws of the
jurisdiction of its incorporation, and Borrower is and will continue to be qualified and licensed to do business in all jurisdictions in which it is required to do so, except where the failure to do so could not reasonably be expected to have a
Material Adverse Effect; the execution, delivery and performance by Borrower of this Agreement, and all other documents contemplated hereby have been duly and validly authorized by all necessary corporate action, and do not violate Borrower’s
formation documents or by-laws, or any law or any material agreement or instrument which is binding upon Borrower or its property. Borrower has no wholly owned or partially owned subsidiaries and is not a partner or joint venturer in any partnership
or joint venture. 
 (b) State of Incorporation; Places of Business; Locations of Collateral. The address set forth in
this Agreement under Borrower’s signature is Borrower’s chief executive office. Other than the chief executive office, the Collateral is located at the address(es) set forth on Exhibit B. 
 (c) Title to Collateral; Permitted Liens. Borrower is now, and will at all times in the future be, the sole owner of all the
Collateral, except for dispositions permitted under clause (iii) of Section 4. The Collateral now is and will remain free and clear of any and all liens, security interests, encumbrances and adverse claims, except for (i) purchase
money security interests in specific items of Equipment; (ii) leases of specific items of Equipment; (iii) liens for taxes, fees, assessments or other governmental charges or levies, either not delinquent or being contested in good faith
by appropriate proceedings, provided the same have no priority over any of Lenders’ security interests; (iv) liens of materialmen, mechanics, warehousemen, carriers, or other similar liens arising in the ordinary course of business and
securing obligations that are not delinquent; (v) licenses or sublicenses granted in the ordinary course of Borrower’s business and any interest or title of a licensor or under any license or sublicense, (vi) leases or subleases
granted in the ordinary course of Borrower’s business, including in connection with Borrower’s leased premises or leased property; and (vii) those liens set forth Exhibit B. 
 (d) Financial Condition, Statements and Reports. The financial statements provided to Lenders by Borrower have been prepared in
accordance with generally accepted accounting principles, consistently applied (“GAAP”). All financial statements now or in the future delivered to Lenders will fairly reflect the financial condition of Borrower, at the times and for the
periods therein stated. Between the last date covered by any such statement provided to Lenders and the date hereof, there has been no circumstance that could constitute or give rise to a Material Adverse Effect. 
 (e) Tax Returns and Payments. Borrower has timely filed, and will timely file, all material tax returns and reports required by
applicable law, and Borrower has timely paid, and will timely pay, all applicable taxes, assessments, deposits and contributions now or in the future owed by Borrower. 
 (f) Compliance with Law. Borrower has complied, and will comply, in all material respects, with all provisions of all applicable
material laws and regulations. 
 (g) Information. All information provided to Lenders by or on behalf of Borrower on
or prior to the date of this Agreement is true and correct in all material respects, and no representation or other statement made by Borrower to Lenders contains any untrue statement of a material fact or omits to state a material fact necessary to
make any statements made to Lenders not misleading at the time made. 
 (h) Litigation. Except as disclosed on
Exhibit B, there is no material claim or litigation pending or (to best of Borrower’s knowledge) threatened against Borrower. Borrower will promptly inform Lenders in writing of any material claim or litigation in the future. 

(i) Subsidiaries. Except as disclosed on Exhibit B, Borrower has no wholly-owned or partially owned subsidiaries and
Exhibit B sets forth all loans by Borrower to, and all investments by Borrower in, any person, entity, corporation partnership or joint venture. 
  

 3. 

 (j) Deposit and Investment Accounts. Borrower maintains only the operating,
savings, deposit, securities and investment accounts listed on Exhibit B. 
 (k) Reports. Borrower will provide
to Lenders in form and substance acceptable to Lenders (i) monthly unaudited financial statements, prepared in accordance with GAAP, consistently applied, within 30 days after the last day of each month; (ii) copies of any borrowing base
certificates and accounts receivable agings, when delivered to any lender to Borrower; (iii) within 15 days of month end, copies of all bank statements, provided that in lieu of this requirement, Borrower may give Lenders on-line, view only
access to its bank accounts; (iv) within 15 days after filing, copies of any reports or statements delivered to the Securities and Exchange Commission; and (iv) upon request, such other information relating to Borrower’s operations
and condition, including information on the status of any acquisitions or equity investments, as Lenders may reasonably request from time to time. Lenders shall have the right to review and copy Borrower’s books and records and audit and
inspect the Collateral, from time to time, upon reasonable notice to Borrower. Each Lender or its officers, employees, or agents shall have a right upon a reasonable notice and during normal business hours to visit Borrower’s premises and
interview Borrower’s officers at Borrower’s expense; provided however that such right shall be limited to two times a year except upon the occurrence of an Event of Default. 
 (l) Senior Loans. Borrower may incur up to $1,500,000 in indebtedness from BFI Finance on the same terms as exist on the date of
this Agreement. Borrower may incur up to $2,500,000 from another senior lender acceptable to Lender, which loan will repay BFI Finance in full, on terms reasonably acceptable to Lenders. The credit facilities of BFI Finance and such other senior
lender(s) are referred to as the “Senior Loans”. 
 (m) Insurance. Borrower will maintain insurance on the
Collateral and Borrower’s business, in amounts and of a type that are customary to businesses similar to Borrower’s, and Lenders will be named in a lenders’ loss payable endorsement in favor of Lenders, in form reasonably acceptable
to Lenders 
 4. Negative Covenants. Without the prior written consent of Lenders, Borrower shall not do any of the following:
(i) permit or suffer a merger, change of control, or acquisition of all or substantially all of Borrower’s assets other than in a transaction, the terms of which provide for immediate payment of all amounts outstanding under this
Agreement, or a merger of any subsidiary of Borrower into Borrower; (ii) acquire any assets outside the ordinary course of business; (iii) except for Permitted Liens, sell, lease, license, encumber or transfer any Collateral except for
sales or non-exclusive licenses in the ordinary course of business (in which case Lenders retain a security interest in the proceeds of such disposition); (iv) pay or declare any dividends on Borrower’s stock; (v) redeem, purchase or
otherwise acquire, any of Borrower’s stock, except for stock from terminated employees or contractors, to the extent required or permitted under any employment or contractor agreements; (vi) make any investments in, or loans or advances
to, any person, including without limitation any investments in, or downstreaming of funds to, any subsidiary or affiliate of Borrower; (vii) except for Permitted Indebtedness, incur any indebtedness, other than trade debt and capital lease
obligations incurred in the ordinary course of business; (viii) make any payment on any of Borrower’s indebtedness that is subordinate to the Obligations, other than in accordance with the subordination agreement, if any, in favor of
Lenders relating thereto, [or as otherwise contemplated by the use of proceeds of the Advance]; (ix) make any deposits or investments into any investment or depository accounts unless they are subject to an account control agreement acceptable
to Lenders, or (x) agree to do any of the foregoing. 
 5. Events of Default. Any one or more of the following shall constitute
an Event of Default under this Agreement: 
 (a) Borrower shall fail to pay any principal of or interest on any Loans
or any other monetary Obligations within ten days after the date due; or 
 (b) Borrower shall fail to comply with any
other provision of this Agreement, which failure is not cured within ten days after the sooner of (i) the date that Borrower has knowledge of that failure or (ii) Borrower’s receipt of notice from Agility; or 
 (c) Any warranty, representation, statement, report or certificate made or delivered to a Lender by Borrower or on Borrower’s
behalf shall be untrue or misleading in a material respect as of the date given or made, or shall become untrue or misleading in a material respect after the date hereof; or 
  

 4. 

 (d) A default or event of default shall occur under any agreement to which
Borrower is a party or by which it is bound (i) resulting in a right by the other party or parties, whether or not exercised, to accelerate the maturity of any indebtedness in excess of $100,000 or (ii) that could have a Material Adverse
Effect, as defined below; or 
 (e) Any portion of Borrower’s assets is attached, seized or levied upon, or a
judgment for more than $250,000 is awarded against Borrower and is not stayed within ten days; or 
 (f) Dissolution,
termination of existence of Borrower; the occurrence of a Dissolution Event; or appointment of a receiver, trustee or custodian, for all or any material part of the property of, assignment for the benefit of creditors by, or the commencement of any
proceeding by or against Borrower under any reorganization, bankruptcy, insolvency, arrangement, readjustment of debt, dissolution or liquidation law or statute of any jurisdiction, now or in the future in effect (except that, in the case of a
proceeding commenced against Borrower, Borrower shall have 60 days after the date such proceeding was commenced to have it dismissed, provided Agility shall have no obligation to make any Loans during such period); or 
 (g) The occurrence of a “Material Adverse Effect”, which shall mean (i) a material adverse change in the business,
prospects, operations, results of operations, assets, liabilities or financial or other condition of Borrower, (ii) the material impairment of Borrower’s ability to perform its Obligations, or (iii) a material adverse change in the
value of the Collateral. 
 6. Remedies. 
 (a) Remedies. Upon the occurrence and during the continuance of any Event of Default, either Lender, at its option, may do any one or more of the following: (a) Accelerate and declare the Obligations to be
immediately due, payable, and performable; (b) Take possession of any or all of the Collateral wherever it may be found, and for that purpose Borrower hereby authorizes each Lender to enter Borrower’s premises without interference to
search for, take possession of, keep, store, or remove any of the Collateral, and remain on the premises or cause a custodian to remain on the premises in exclusive control thereof, without charge by Borrower for so long as such Lender reasonably
deems it necessary in order to complete the enforcement of its rights under this Agreement or any other agreement; provided, however, that should Lender seek to take possession of any of the Collateral by Court process, Borrower hereby waives:
(i) any bond and any surety or security relating thereto; (ii) any demand for possession prior to the commencement of any suit or action to recover possession thereof; and (iii) any requirement that Lender retain possession of, and
not dispose of, any such Collateral until after trial or final judgment; (c) Require Borrower to assemble any or all of the Collateral and make it available to Agility at places designated by Agility; (d) Complete the processing of any
Collateral prior to a disposition thereof and, for such purpose and for the purpose of removal, Lender shall have the right to use Borrower’s premises, equipment and all other property without charge by Borrower; (e) Collect and dispose of
and realize upon any investment property, including withdrawal of any and all funds from any deposit or securities accounts; (f) Dispose of any of the Collateral, at one or more public or private sales, in lots or in bulk, for cash, exchange or
other property, or on credit, and to adjourn any such sale from time to time without notice other than oral announcement at the time scheduled for sale; and (g) Demand payment of, and collect any accounts, general intangibles or other
Collateral and, in connection therewith, Borrower irrevocably authorizes each Lender to endorse or sign Borrower’s name on all collections, receipts, instruments and other documents, and, in Lender’s good faith business judgment, to grant
extensions of time to pay, compromise claims and settle accounts, general intangibles and the like for less than face value; Borrower grants each Lender a license, exercisable from and after an Event of Default has occurred, to use and copy any
trademarks, service marks and other intellectual property in which Borrower has an interest to effect any of the foregoing remedies. All reasonable attorneys’ fees, expenses, costs, liabilities and obligations incurred by a Lender with respect
to the foregoing shall be added to and become part of the Obligations, and shall be due on demand. 
 (b) Application of
Proceeds. All proceeds realized as the result of any sale or other disposition of the Collateral shall be applied by Lenders first to the reasonable costs, expenses, liabilities, obligations and attorneys’ fees incurred by a Lender in the
exercise of any rights under this Agreement, second to any fees and Obligations other than interest and principal, pro rata to each Lender, third to the interest due upon any of the Obligations, pro rata to each Lender, and fourth to the principal
of the Obligations, pro rata to each Lender, in such order as Lenders shall determine in its sole discretion. Any surplus shall be paid to Borrower or other persons legally entitled thereto; Borrower shall remain liable to Lenders for any
deficiency. 
  

 5. 

 (c) Remedies Cumulative. In addition to the rights and remedies set forth in this
Agreement, each Lender shall have all the other rights and remedies accorded a secured party under the California Uniform Commercial Code and under all other applicable laws, and under any other instrument or agreement now or in the future entered
into between a Lender and Borrower, and all of such rights and remedies are cumulative and none is exclusive. Exercise or partial exercise of one or more of its rights or remedies shall not be deemed an election, nor bar a Lender from subsequent
exercise or partial exercise of any other rights or remedies. The failure or delay of a Lender to exercise any rights or remedies shall not operate as a waiver thereof, but all rights and remedies shall continue in full force and effect until all of
the Obligations have been fully paid and performed. 
 (d) Power of Attorney. After the occurrence and during the
continuance of an Event of Default, Borrower irrevocably appoints each Lender (and any of such Lender’s designated employees or agents) as Borrower’s true and lawful attorney in fact to: endorse Borrower’s name on any checks or other
forms of payment; make, settle and adjust all claims under and decisions with respect to Borrower’s policies of insurance; settle and adjust disputes and claims respecting accounts, general intangibles and other Collateral; execute and deliver
all notices, instruments and agreements in connection with the perfection of the security interest granted in this Agreement; sell, lease or otherwise dispose of all or any part of the Collateral; and take any other action or sign any other
documents required to be taken or signed by Borrower, or reasonably necessary to enforce the rights or remedies or otherwise carry out the purposes of this Agreement. The appointment of each Lender as Borrower’s attorney in fact, and each of
such Lender’s rights and powers, being coupled with an interest, are irrevocable until all Obligations owing to Lenders have been paid and performed in full. 
 7. Waivers. The failure of a Lender at any time or times to require Borrower to strictly comply with any of the provisions of this Agreement or any other present or future agreement between Borrower and a
Lender shall not waive or diminish any right of a Lender later to demand and receive strict compliance therewith. Any waiver of any default shall not waive or affect any other default, whether prior or subsequent, and whether or not similar. None of
the provisions of this Agreement or any other agreement shall be deemed to have been waived except by a specific written waiver signed by an authorized officer of a Lender. Borrower waives demand, protest, notice of protest and notice of default or
dishonor, notice of payment and nonpayment, release, compromise, settlement, extension or renewal of any commercial paper, instrument, account, general intangible, document or guaranty at any time held by a Lender on which Borrower is or may in any
way be liable, and notice of any action taken by a Lender, unless expressly required by this Agreement. 
 8. Indemnity. Borrower
shall indemnify each Lender for any costs or liabilities, including reasonable attorneys’ fees, incurred by such Lender in connection with this Agreement, except for costs or liabilities caused by Lender’s gross negligence or willful
misconduct. 
 9. Confidentiality. In handling any confidential non-public information provided to a Lender by Borrower, such Lender
shall exercise the same degree of care that it exercises with respect to its own proprietary information of the same types to maintain the confidentiality of the same, except that disclosure of such information may be made (i) to subsidiaries
or affiliates of such Lender in connection with their present or prospective business relations with Borrower, (ii) to prospective transferees or purchasers of any interest in the Obligations, provided that they have entered into a comparable
confidentiality agreement with respect thereto, (iii) as required by law, regulations, rule or order, subpoena, judicial order or similar order, (iv) as may be required in connection with the examination, audit or similar investigation of
Lender, and (v) as Lender may deem appropriate in connection with the exercise of any remedies hereunder. Confidential information shall not include information that either: (a) is in the public domain, or becomes part of the public
domain, after disclosure to a Lender through no fault of such Lender; or (b) is disclosed to a Lender by a third party, provided such Lender does not have actual knowledge that such third party is prohibited from disclosing such information.

 10. Governing Law; Jurisdiction; Venue. This Agreement and all acts and transactions hereunder and all rights and obligations of
Lenders and Borrower shall be governed by the internal laws (and not the conflict of laws rules) of the State of California. Subject to Section 12, all actions and proceedings relating directly or indirectly to this Agreement shall be litigated
in courts located in Santa Clara County, California, each party consents to the 

  

 6. 

 
jurisdiction and venue of any such court and consents to service of process in any such action or proceeding by personal delivery or any other method
permitted by law, and waives any and all rights Borrower may have to object to the jurisdiction of any such court, or to transfer or change the venue of any such action or proceeding. 
 11. MUTUAL WAIVER OF JURY TRIAL BORROWER AND LENDERS EACH WAIVE THE RIGHT TO TRIAL BY JURY IN ANY ACTION OR PROCEEDING BASED UPON, ARISING OUT OF, OR
IN ANY WAY RELATING TO, THIS AGREEMENT OR ANY OTHER PRESENT OR FUTURE INSTRUMENT OR AGREEMENT BETWEEN AGILITY AND BORROWER, OR ANY CONDUCT, ACTS OR OMISSIONS OF AGILITY OR BORROWER OR ANY OF THEIR DIRECTORS, OFFICERS, EMPLOYEES, AGENTS, ATTORNEYS OR
ANY OTHER PERSONS AFFILIATED WITH AGILITY OR BORROWER, IN ALL OF THE FOREGOING CASES, WHETHER SOUNDING IN CONTRACT, TORT OR OTHERWISE. IF THIS JURY WAIVER IS FOR ANY REASON UNENFORCEABLE, THE PARTIES AGREE TO RESOLVE ALL CLAIMS, CAUSES AND
DISPUTES THROUGH JUDICIAL REFERENCE PURSUANT TO CODE OF CIVIL PROCEDURE SECTION 638 ET SEQ BEFORE A MUTUALLY ACCEPTABLE REFEREE SITTING WITHOUT A JURY OR, IF NO AGREEMENT ON THE REFEREE IS REACHED, BEFORE A REFEREE SELECTED BY THE PRESIDING JUDGE OF
THE CALIFORNIA SUPERIOR COURT FOR SANTA BARBARA COUNTY. THIS PROVISION SHALL NOT RESTRICT A PARTY FROM EXERCISING NONJUDICIAL REMEDIES UNDER THE CODE. 
 12. Co-Borrowers. Solely for purposes of this Section 12, ALPHA INNOTECH CORP., a Delaware corporation and ALPHA INNOTECH CORPORATION, a California corporation are each referred to individually, as a
“Borrower” and, collectively, the “Borrowers”. 
 (a) Co-Borrowers. Borrowers are jointly
and severally liable for the Obligations and Agility may proceed against one Borrower to enforce the Obligations without waiving its right to proceed against the other Borrower. This Agreement and the Loan Documents are a primary and original
obligation of each Borrower and shall remain in effect notwithstanding future changes in conditions, including any change of law or any invalidity or irregularity in the creation or acquisition of any Obligations or in the execution or delivery of
any agreement between Agility and any Borrower. Each Borrower shall be liable for existing and future Obligations as fully as if all of the Advance was advanced to such Borrower. Agility may rely on any certificate or representation made by any
Borrower as made on behalf of, and binding on, all Borrowers. Each Borrower appoints each other Borrower as its agent with all necessary power and authority to give and receive notices, certificates or demands for and on behalf of both Borrowers, to
act as disbursing agent for receipt of any loans on behalf of each Borrower and to apply to Agility on behalf of each Borrower for the Advance, any waivers and any consents. This authorization cannot be revoked, and Agility need not inquire as to
one Borrower’s authority to act for or on behalf of another Borrower. 
 (b) Subrogation and Similar Rights. Each
Borrower irrevocably waives, until all Obligations are satisfied, all rights that it may have at law or in equity (including, without limitation, any law subrogating the Borrower to the rights of Agility under the Loan Documents) to seek
contribution, indemnification, or any other form of reimbursement from any other Borrower, or any other Person now or hereafter primarily or secondarily liable for any of the Obligations, for any payment made by the Borrower with respect to the
Obligations in connection with the Loan Documents or otherwise and all rights that it might have to benefit from, or to participate in, any security for the Obligations as a result of any payment made by the Borrower with respect to the Obligations
in connection with the Loan Documents or otherwise. Any agreement providing for indemnification, reimbursement or any other arrangement prohibited under this Section shall be null and void. If any payment is made to a Borrower in contravention of
this Section, such Borrower shall hold such payment in trust for Agility and such payment shall be promptly delivered to Agility for application to the Obligations, whether matured or unmatured. 
 (c) Waivers of Notice. Each Borrower waives, to the extent permitted by law, notice of acceptance hereof; notice of the existence,
creation or acquisition of any of the Obligations; notice of an Event of Default except as set forth herein; notice of the amount of the Obligations outstanding at any time; notice of any adverse change in the financial condition of any other
Borrower or of any other fact that might increase the Borrower’s risk; presentment for payment; demand; protest and notice thereof as to any instrument; and all other notices and demands to which the Borrower would otherwise be entitled by
virtue of being a co-borrower or a surety. Each Borrower waives any defense arising from any defense of any other Borrower, or by reason of the cessation from any cause whatsoever of the liability of any other Borrower. Agility’s failure at any
time to require strict performance by 

  

 7. 

 
any Borrower of any provision of the Loan Documents shall not waive, alter or diminish any right of Agility thereafter to demand strict compliance and
performance therewith. Each Borrower also waives any defense arising from any act or omission of Agility that changes the scope of the Borrower’s risks hereunder. Each Borrower hereby waives any right to assert against Agility any defense
(legal or equitable), setoff, counterclaim, or claims that such Borrower individually may now or hereafter have against another Borrower or any other Person liable to Agility with respect to the Obligations in any manner or whatsoever. 

(d) Subrogation Defenses. Until all Obligations are paid in full and Agility has no further obligation to make Credit Extensions
to Borrowers, each Borrower hereby waives any defense based on impairment or destruction of its subrogation or other rights against any other Borrower and waives all benefits which might otherwise be available to it under California Civil Code
Sections 2809, 2810, 2819, 2839, 2845, 2848, 2849, 2850, 2899, and 3433 and California Code of Civil Procedure Sections 580a, 580b, 580d and 726, as those statutory provisions are now in effect and hereafter amended, and under any other similar
statutes now and hereafter in effect. 
 (e) Right to Settle, Release. 
 (i) The liability of Borrowers hereunder shall not be diminished by (i) any agreement, understanding or representation that
any of the Obligations is or was to be guaranteed by another Person or secured by other property, or (ii) any release or unenforceability, whether partial or total, of rights, if any, which Agility may now or hereafter have against any other
Person, including another Borrower, or property with respect to any of the Obligations. 
 (ii) Without notice to any
given Borrower and without affecting the liability of any given Borrower hereunder, Agility may (i) compromise, settle, renew, extend the time for payment, change the manner or terms of payment, discharge the performance of, decline to enforce,
or release all or any of the Obligations with respect to any other Borrower by written agreement with such other Borrower, (ii) grant other indulgences to another Borrower in respect of the Obligations, (iii) modify in any manner any
documents relating to the Obligations with respect to any other Borrower by written agreement with such other Borrower, (iv) release, surrender or exchange any deposits or other property securing the Obligations, whether pledged by a Borrower
or any other Person, or (v) compromise, settle, renew, or extend the time for payment, discharge the performance of, decline to enforce, or release all or any obligations of any guarantor, endorser or other Person who is now or may hereafter be
liable with respect to any of the Obligations. 
 (f) Subordination. All indebtedness of a Borrower now or hereafter
arising held by another Borrower is subordinated to the Obligations and the Borrower holding the indebtedness shall take all actions reasonably requested by Agility to effect, to enforce and to give notice of such subordination. 
 13. General. This Agreement and such other written agreements, documents and instruments as may be executed in connection herewith are the final,
entire and complete agreement between Borrower and Agility and supersede all prior and contemporaneous negotiations and oral representations and agreements, all of which are merged and integrated in this Agreement. There are no oral understandings,
representations or agreements between the parties which are not set forth in this Agreement or in other written agreements signed by the parties in connection herewith. The terms and provisions of this Agreement may not be waived or amended, except
in a writing executed by Borrower and a duly authorized officer of each Lender. A Lender may assign all or any part of its interest in this Agreement and the Obligations to any person or entity, or grant a participation in, or security interest in,
any interest in this Agreement, with notice to, but without consent of, Borrower. Borrower may not assign any rights under or interest in this Agreement without Lenders’ prior written consent. This Agreement may be executed in two or more
counterparts, each of which shall be deemed an original, but all of which shall constitute one agreement. Upon termination of this Agreement and repayment of all amounts outstanding, Lenders will terminate their security interests at Borrower’s
expense. 
 14. Publicity. Borrower authorizes each Lender to use Borrower’s tradenames and logos in such Lender’s marketing
materials in respect of the transactions evidenced by this Agreement. 
  

 8. 

									
	AGILITY CAPITAL, LLC	 		 	ALPHA INNOTECH CORPORATION
					
	By:	 	 	 		 	By:	 	 
	Title:	 	 	 		 	Title:	 	 
			
	Address for notices:	 		 	Address for notices:
			
	Agility Capital, LLC	 		 	2401 Merced Street
	226 E. Canon Perdido Street, Suite F	 		 	San Leandro, CA 94577
	Santa Barbara, CA 93101	 		 	Attn:	 	Chief Executive Officer
	Attn:	 	Daniel Corry	 		 	Fax:	 	__________________
	Fax:	 	805-568-0425	 		 		 	
				
	Pro Rata Share:         %	 		 		 	

  

									
	MONTAGE CAPITAL, LLC	 		 	ALPHA INNOTECH CORP.
					
	By:	 	 	 		 	By:	 	 
	Title:	 	 	 		 	Title:	 	 
			
	Address for notices:	 		 	Address for notices:
			
	Montage Capital, LLC	 		 	2401 Merced Street
	5201 Great America Parkway, Suite 320	 		 	San Leandro, CA 94577
	Santa Clara, CA 95054	 		 	Attn:	 	Chief Executive Officer
	Attn:	 	Damon Doe	 		 	Fax:	 	__________________
	Fax:	 		 		 		 	
				
	Pro Rata Share:         %	 		 		 	

  

 9. 

 EXHIBIT A 
 COLLATERAL DESCRIPTION ATTACHMENT 
 TO LOAN AND SECURITY AGREEMENT

 All personal property of Borrower (herein referred to as “Borrower” or “Debtor”) whether presently existing or
hereafter created or acquired, and wherever located, including, but not limited to: 
 (a) all accounts (including health-care-insurance
receivables), chattel paper (including tangible and electronic chattel paper), deposit accounts, documents (including negotiable documents), equipment (including all accessions and additions thereto), general intangibles (including copyrights,
patents, trademarks, goodwill and all intellectual property, payment intangibles and software), goods (including fixtures), instruments (including promissory notes), inventory (including all goods held for sale or lease or to be furnished under a
contract of service, and including returns and repossessions), investment property (including securities and securities entitlements), letter of credit rights, money, and all of Debtor’s books and records with respect to any of the foregoing,
and the computers and equipment containing said books and records; and 
 (b) any and all cash proceeds and/or noncash proceeds of any of the
foregoing, including, without limitation, insurance proceeds, and all supporting obligations and the security therefor or for any right to payment. All terms above have the meanings given to them in the California Uniform Commercial Code, as amended
or supplemented from time to time.Form of Warrant

 Exhibit 10.16 
 THE SECURITIES REPRESENTED THIS WARRANT HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, AND HAVE BEEN ACQUIRED FOR INVESTMENT AND NOT WITH A VIEW TO, OR IN CONNECTION WITH, THE SALE OR DISTRIBUTION THEREOF. NO SUCH
SALE OR DISTRIBUTION MAY BE EFFECTED WITHOUT AN EFFECTIVE REGISTRATION THEREOF OR AN OPINION OF COUNSEL IN A FORM SATISFACTORY TO THE COMPANY THAT SUCH REGISTRATION IS NOT REQUIRED UNDER THE SECURITIES ACT OF 1933, AS AMENDED. 
 WARRANT TO PURCHASE STOCK 
  

			
	Corporation:	  	ALPHA INNOTECH CORP., a Delaware corporation
	Number of Shares:	  	
	Class of Stock:	  	Common
	Initial Exercise Price:	  	$0.80
	Issue Date:	  	May 9, 2008
	Expiration Date:	  	October 31, 2014

 THIS WARRANT CERTIFIES THAT _______________
or registered assignee (“Holder”) is entitled to purchase the number of fully paid and nonassessable shares (the “Shares”) of Common Stock of ALPHA INNOTECH CORP. (the “Company”), in the number, at the price, and for
the term specified above. If any amount is outstanding on December 31, 2008 under the Loan Agreement dated as of the Issue Date (the “Loan Agreement”), the number of shares that may be acquired under this Warrant shall automatically
increase by a number that is 7.5% of such outstanding balance divided by the Exercise Price. If any amount is outstanding on April 30, 2009 under the Loan Agreement, the number of Shares that may be acquired under this Warrant shall
automatically increase by a number that is 7.5% of such outstanding balance divided by the Exercise Price. If any amount is outstanding under the Loan Agreement after the occurrence of an Event of Default, the number of Shares that may be acquired
under this Warrant shall increase by 50,000 on the day after the Maturity Date, and by 100,000 on each 30th day thereafter for so long as any amount
remains outstanding under the Loan Agreement. 
 ARTICLE 1. EXERCISE 
 1.1 Method of Exercise. Holder may exercise this Warrant by delivering this Warrant and a duly executed Notice of Exercise in substantially the form attached as Appendix 1 to the principal office of the
Company. Unless Holder is exercising the conversion right set forth in Section 1.2, Holder shall also deliver to the Company a check for the aggregate Warrant Price for the Shares being purchased. 
 1.2 Conversion Right. In lieu of exercising this Warrant as specified in Section 1.1, Holder may from time to time convert this Warrant, in
whole or in part, into a number of Shares computed using the following formula: 
  

					
	X =	 	Y (A - B)	  	
		 	A	  	

  

			
	Where	  	X = The number of shares of common stock to be issued to the Registered Holder.
		
		  	Y = The number of shares of common stock purchasable under this Warrant (at the date of such calculation).
		
		  	A = The fair market value of one share of common stock (at the date of such calculation).
		
		  	B = The Exercise Price (as adjusted to the date of such calculation). The fair market value of the Shares shall be determined pursuant to Section 1.3.

 1.3 Fair Market Value. If the Company’s common stock is traded regularly in a public market,
the fair market value of the Shares shall be the closing price of the Shares reported for the business day immediately before Holder delivers its Notice of Exercise to the Company. If the Company’s common stock is actively traded
over-the-counter, the fair market value shall be deemed to be the average of the closing bid or sales price (whichever is applicable) over the 30 day period ending three days before the date of calculation. If the Company’s common stock is not
regularly traded in a public market, the Board of Directors of the Company shall determine fair market value in its reasonable good faith judgment. 
 1.4 Delivery of Certificate and New Warrant. Promptly after Holder exercises or converts this Warrant, the Company shall deliver to Holder certificates for the Shares acquired and, if this Warrant has not been fully exercised or
converted and has not expired, a new Warrant representing the Shares not so acquired. 
 1.5 Replacement of Warrants. On receipt of
evidence reasonably satisfactory to the Company of the loss, theft, destruction or mutilation of this Warrant and, in the case of loss, theft or destruction, on delivery of an indemnity agreement reasonably satisfactory in form and amount to the
Company or, in the case of mutilation, or surrender and cancellation of this Warrant, the Company at its expense shall execute and deliver, in lieu of this Warrant, a new warrant of like tenor. 
 ARTICLE 2. ADJUSTMENTS TO THE SHARES. 
 2.1 Stock
Dividends, Splits. If the Company declares or pays a dividend on its Common stock payable in Common stock, or other securities, subdivides the outstanding Common stock into a greater amount of Common stock, then upon exercise of this Warrant,
for each Share acquired, Holder shall receive, without cost to Holder, the total number and kind of securities to which Holder would have been entitled had Holder owned the Shares of record as of the date the dividend or subdivision occurred. If the
Company makes any other distribution with respect to the Shares, then in each case the Company shall cause Holder upon exercise or conversion of this Warrant to receive a proportionate share of that distribution as though it were the holder of the
Shares as of the record date fixed for the determination of stockholders of the Company entitled to receive that distribution. 
 2.2
Reclassification, Exchange or Substitution. Upon any reclassification, exchange, substitution, or other event that results in a change of the number and/or class of the securities issuable upon exercise or conversion of this Warrant, Holder
shall be entitled to receive, upon exercise or conversion of this Warrant, the number and kind of securities and property that Holder would have received for the Shares if this Warrant had been exercised immediately before such reclassification,
exchange, substitution, or other event. Upon the closing of any sale, license, or other disposition of all or substantially all of the assets (including intellectual property) of the Company, or any reorganization, consolidation, or merger of the
Company where the holders of the Company’s securities before the transaction beneficially own less than 50% of the outstanding voting securities of the surviving entity after the transaction, the successor entity shall assume the obligations of
this Warrant, and this Warrant thereafter shall be exercisable for the same securities, cash and property as would be payable for the Shares issuable upon exercise of the unexercised portion of this Warrant as if such Shares were outstanding on the
record date for the Acquisition and subsequent closing. The Warrant Price shall be adjusted accordingly. The Company or its successor shall promptly issue to Holder a new Warrant for such new securities or other property. The new Warrant shall
provide for adjustments that shall be as nearly equivalent as may be practicable to the adjustments provided for in this Article 2. The provisions of this Section 2.2 shall similarly apply to successive reclassifications, exchanges,
substitutions, or other events. 
 2.3 Adjustments for Combinations, Etc. If the outstanding Shares are combined or consolidated, by
reclassification or otherwise, into a lesser number of shares, the Warrant Price shall be proportionately increased. 
 2.4 Weighted
Average Adjustment. If the Company issues additional common shares, other than Excluded Stock, as defined below (and excluding subdivisions, stock dividends, combinations, reclassifications and reorganizations which are covered in Sections 2.1,
2.2 and 2.3 above) after the date of the Warrant and the consideration per additional common share is less than the Warrant Price in effect immediately before such issue shall be reduced, concurrently with such Issue, to a price determined by
multiplying the Warrant Price by a fraction: 
 (a) the numerator of which is the amount of Common Stock Outstanding
immediately before such Issue plus the amount of common stock that the aggregate consideration received by the Company for the additional common shares would purchase at the Warrant Price in effect immediately before such Issue, and 

 (b) the denominator of which is the amount of Common Stock Outstanding immediately before
such issue plus the number of such additional common shares. 
 Upon each adjustment of the Warrant Price, the number of Shares issuable upon exercise of the
Warrant shall be increased to equal the quotient obtained by dividing (a) the product resulting from multiplying (i) the number of Shares issuable upon exercise of the Warrant and (ii) the Warrant Price, in each case as in effect
immediately before such adjustment, by (b) the adjusted Warrant Price. 
 “Excluded Stock” means (a) securities issued, or deemed issued,
to directors, officers, employees or consultants of the Company or a subsidiary of the Company in connection with their service as directors of the Company or a subsidiary of the Company, their employment by the Company or a subsidiary of the
Company or their retention as consultants by the Company or a subsidiary of the Company under the Company stock option plans; (b) shares of common stock issuable upon exercise of warrants outstanding as of the date hereof; (c) shares of
common stock issued, or deemed issued (as provided below), pursuant to a merger, consolidation or stock or asset acquisition approved by the Company’s Board of Directors; (d) shares issued, or deemed issued, at any time after May 9,
2009, to persons or entities with which the Company has business relationships, provided such issuances are for other than primary equity financing purposes and provided that, at the time of such issuance, the aggregate of such issuance and similar
issuances in the preceding twelve-month period does not exceed 2% of the then Common Stock Outstanding of the Company (assuming full conversion and exercise of all convertible and exercisable securities); and (e) shares issued, or deemed
issued, pursuant to any equipment leasing arrangement or debt financing from a bank or similar institution entered into at any time after May 9, 2009 and approved by the Board of Directors, provided such financing is primarily for non-equity
purposes. 
 “Common Stock Outstanding” means the total number of shares of common stock outstanding plus the total number of shares of common
stock issuable upon conversion or exercise of outstanding convertible securities (including this Warrant, all other warrants and any options) immediately prior to the issuance of the additional shares of common stock. 
 2.5 No Impairment. The Company shall not, by amendment of its Articles of Incorporation or through a reorganization, transfer of assets,
consolidation, merger, dissolution, issue, or sale of securities or any other voluntary action, avoid or seek to avoid the observance or performance of any of the terms to be observed or performed under this Warrant by the Company, but shall at all
times in good faith assist in carrying out all the provisions of this Article 2 and in taking all such action as may be necessary or appropriate to protect Holder’s rights under this Article against impairment. 
 2.6 Certificate as to Adjustments. Upon each adjustment of the Warrant Price, the Company at its expense shall promptly compute such adjustment,
and furnish Holder with a certificate of its Chief Financial Officer setting forth such adjustment and the facts upon which such adjustment is based. The Company shall, upon written request, furnish Holder a certificate setting forth the Warrant
Price in effect upon the date thereof and the series of adjustments leading to such Warrant Price. No fractional shares of common stock will be issued in connection with any adjustments or exercise hereunder. In lieu of any fractional shares which
would otherwise be issuable, the Company shall pay cash equal to the product of such fraction multiplied by the fair market value of one share of common stock on the date of exercise, as determined in good faith by the Company’s Board of
Directors. 
 ARTICLE 3. REPRESENTATIONS AND COVENANTS OF THE COMPANY. 
 3.1 Representations and Warranties. The Company represents and warrants to the Holder as follows: 
 (a) All Shares that may be issued upon the exercise of the purchase right represented by this Warrant, shall, upon issuance, be duly authorized, validly issued, fully paid and nonassessable, and free of any liens and
encumbrances except for restrictions on transfer provided for herein or under applicable federal and state securities laws. 

 3.2 Notice of Certain Events. If the Company proposes at any time (a) to declare any dividend
or distribution upon its Common stock, whether in cash, property, stock, or other securities and whether or not a regular cash dividend; (b) to effect any reclassification or recapitalization of Common stock; (c) to merge or consolidate
with or into any other corporation, or sell, lease, license, or convey all or substantially all of its assets, or to liquidate, dissolve or wind up; or (d) offer holders of registration rights the opportunity to participate in an underwritten
public offering of the company’s securities for cash, then, in connection with each such event, the Company shall give Holder (1) at least 20 days prior written notice of the date on which a record will be taken for such dividend,
distribution, or subscription rights (and specifying the date on which the holders of Common stock will be entitled thereto) or for determining rights to vote, if any, in respect of the matters referred to in (a) above; (2) in the case of
the matters referred to in (c) and (c) above at least 20 days prior written notice of the date when the same will take place (and specifying the date on which the holders of Common stock will be entitled to exchange their Common stock for
securities or other property deliverable upon the occurrence of such event); and (3) in the case of the matter referred to in (d) above, the same notice as is given to the holders of such registration rights. 
 3.3 Registration Rights. The Shares shall be included under such investor rights agreement or registration rights agreement as the Company may
enter into from time to time with substantially the same rights as accorded to other Shares thereunder. 
 3.4 Information Rights. So
long as the Holder holds this Warrant and/or any of the Shares, the Company shall deliver to the Holder (a) within ninety (90) days after the end of each fiscal year of the Company, the annual audited financial statements of the Company
certified by independent public accountants of recognized standing and (b) within forty-five (45) days after the end of each of the first three quarters of each fiscal year, the Company’s quarterly, unaudited financial statements,
provided Company need not provide such information for any period in which Company has filed Form 10Q or 10-K with the Securities and Exchange Commission. 
 3.5 No Shareholder Rights. This Warrant, by itself, as distinguished from any shares purchased hereunder, shall not entitle the Holder to any of the rights of a shareholder of the Company. 
 ARTICLE 4. MISCELLANEOUS. 
 4.1 Term. This
Warrant is exercisable, in whole or in part, at any time and from time to time on or until the Expiration Date set forth above. 
 4.2
Legends. This Warrant and the Shares (and the securities issuable, directly or indirectly, upon conversion of the Shares, if any) shall be imprinted with a legend in substantially the following form: 
 THE SECURITIES REPRESENTED THIS WARRANT HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, AND HAVE BEEN ACQUIRED FOR INVESTMENT AND
NOT WITH A VIEW TO, OR IN CONNECTION WITH, THE SALE OR DISTRIBUTION THEREOF. NO SUCH SALE OR DISTRIBUTION MAY BE EFFECTED WITHOUT AN EFFECTIVE REGISTRATION THEREOF OR AN OPINION OF COUNSEL IN A FORM SATISFACTORY TO THE COMPANY THAT SUCH REGISTRATION
IS NOT REQUIRED UNDER THE SECURITIES ACT OF 1933, AS AMENDED 
 4.3 Compliance with Securities Laws on Transfer. This Warrant and the
Shares issuable upon exercise this Warrant (and the securities issuable, directly or indirectly, upon conversion of the Shares, if any) may not be transferred or assigned in whole or in part without compliance with applicable federal and state
securities laws by the transferor and the transferee. 
 4.4 Transfer Procedure. Subject to the provisions of Section 4.3, Holder
may transfer all or part of this Warrant or the Shares issuable upon exercise of this Warrant (or the securities issuable, directly or indirectly, upon conversion of the Shares, if any) by giving the Company notice of the portion of the Warrant
being transferred setting forth the name, address and taxpayer identification number of the transferee and surrendering this Warrant to the Company for reissuance to the transferee(s) (and Holder, if applicable), provided that no such notice shall
be required for a transfer to an affiliate of Holder. 

 4.5 Notices. All notices and other communications from the Company to the Holder, or vice versa,
shall be deemed delivered and effective when given personally or mailed by first-class registered or certified mail, postage prepaid, at such address as may have been furnished to the Company or the Holder, as the case may be, in writing by the
Company or such Holder from time to time. 
 4.6 Waiver. This Warrant and any term hereof may be changed, waived, discharged or
terminated only by an instrument in writing signed by the party against which enforcement of such change, waiver, discharge or termination is sought. 
 4.7 Attorneys’ Fees. In the event of any dispute between the parties concerning the terms and provisions of this Warrant, the party prevailing in such dispute shall be entitled to collect from the other
party all costs incurred in such dispute, including reasonable attorneys’ fees. 
 4.8 Governing Law. This Warrant shall be
governed by and construed in accordance with the laws of the State of California, without giving effect to its principles regarding conflicts of law. 
 4.9 Representations of Holder. In consideration of the receipt of this Warrant, Holder represents to the Company as follows: 
 (a) Holder is aware of the Company’s business affairs and financial condition, and has acquired information about the Company
sufficient to reach an informed and knowledgeable decision to acquire this Warrant. 
 (b) Holder is acquiring the Warrant for
its own account for investment purposes only and not with a view to, or for the resale in connection with, any “distribution” thereof in violation of the Securities Act of 1933, as amended (the “Act”). 
 (c) Holder understands that the Warrant has not been registered under the Act in reliance upon a specific exemption therefrom, which
exemption depends upon, among other things, the bona fide nature of Holder’s investment intent as expressed herein. Holder further understands that the Warrant must be held indefinitely unless subsequently registered under the Act and qualified
under any applicable state securities laws, or unless exemptions from registration and qualification are otherwise available. Holder is aware of the provisions of Rule 144, promulgated under the Act. 
 (d) Holder is an “accredited investor” as such term is defined in Rule 501 of Regulation D promulgated under the Act.

			
	ALPHA INNOTECH CORP.
		
	By:	 	 
	Name:	 	 
	Title:	 	 

 APPENDIX 1 
 NOTICE OF EXERCISE 
 1. The undersigned hereby elects to purchase ______________ shares of the Common
Stock of ALPHA INNOTECH CORP. pursuant to the terms of the attached Warrant, and tenders herewith payment of the purchase price of such shares in full. 
 1. The undersigned hereby elects to convert the attached Warrant into Shares in the manner specified in the Warrant. This conversion is exercised with respect to ______________ of the Shares covered by the Warrant.

 [Strike paragraph that does not apply.] 
 2. Please issue a certificate or certificates representing said shares in the name of the undersigned or in such other name as is specified below: 
 ____________________ 
 ____________________ 
 Or Registered Assignee 
 3. The undersigned represents it is acquiring the shares solely for its own account and not as a nominee for any other party and not with a view toward
the resale or distribution thereof except in compliance with applicable securities laws. 
  

	
	or Registered Assignee
	
	  
	(Signature)
	
	  
	(Date)

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00142-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00142-of-00352.parquet"}]]